Want to join the conversation?
$A expects FY16 revenue of $4.16-4.18Bil and non-GAAP earnings of $1.88-1.92 per share. 3Q16 revenue is expected to be in the range of $1.03-1.05Bil and non-GAAP earnings are expected to be $0.45-0.47 per share. $A has upped its full-year operating cash flow guidance from $650MM to $740MM, with no change to its CapEx guidance of $140MM.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)